2023
DOI: 10.21608/bfsa.2023.214630.1759
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol lipid based nanoparticles show a promising outcome on induced non alcoholic fatty liver disease

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles